TABLE 2.
Modified types and sites of MG‐αLA (60°C, 80°C)
| Sequence | +Da | Modification types and modification sites | |
|---|---|---|---|
| 60°C | 80°C | ||
| CEVFRELKDLK | 54 | MG‐H1 (R29) | MG‐H1 (R29) |
| CEVFRELKDLK | 72 | MG‐DH (R29) | ‐ |
| CEVFRELKDLK | 80 | Argpyrimidine (R29) | Argpyrimidine (R29) |
| CEVFRELKDLK | 144 | THP (R29) | THP (R29) |
| CEVFRELKDLK | 126 | DHP (R29) | DHP (R29) |
| CEVFRELKDLK | 72 | CEL (K32) | CEL (K32) |
| CEVFRELKDLK | 108 | Pyrraline (K32) | ‐ |
| IWCKDDQNPHSSNICNISCDK | 58 | CML (K81) | CML (K81) |
| IWCKDDQNPHSSNICNISCDK | 72 | CEL (K81) | ‐ |
| IWCKDDQNPHSSNICNISCDK | 40 | Pyr‐CML (K98) | ‐ |
| IWCKDDQNPHSSNICNISCDK | 58 | CML (K98) | CML (K98) |
| IWCKDDQNPHSSNICNISCDK | 72 | CEL (K98) | CEL (K98) |
| FLDDDLTDDIMCVKK | 40 | Pyr‐CML (K112) | Pyr‐CML (K112) |
| FLDDDLTDDIMCVKK | 72 | CEL (K112) | CEL (K112) |
“‐” Indicates “not detected.”